INTRODUCTION
Breast cancer is one of the most common malignancies in the United States affecting one in nine women.
Overexpression of the human epidermal growth factor receptor-2 (HER 2, also known as c-erbB2 or c-neu) is associated with increased progression and metastasis, an aggressive clinical course, and decreased disease-free survival in human breast cancer patients' (1) . Accumulating evidence suggests that in addition to HER 2 over expression, the heregulin (HRG, a combinatorial ligand for HER 3, HER 4) pathway be involved in the progression of breast cancer cells to a more invasive phenotype (2) (3) (4) (5) . Exposure of cells to growth factors induces cytoskeleton reorganization, lamellipodia formation, and membrane ruffling; such changes contribute to increased cell migration and invasion (3, 6) . Members of Rho family of the small GTPases Rac1, Cdc42 and RhoA have been implicated in the regulation of cytoskeletal rearrangements; RhoA is involved in the maintenance of actin stress-fibers and focal adhesion points; Rac1 in the formation of lamellipodia and membrane ruffles (7) ; and Cdc42 in the formation of peripheral actin microspikes and filopodia (8) . The small GTPases also regulate gene expression: Cdc42 and Rac1 activate Jun N -terminal kinase JNK and p38 mitogen-activated protein kinase (p38MAPK) pathways (9) . Thus GTPases Rac1, Cdc42 and Rho are implicated in cellular transformation (10, 11) . Cdc42 and Rac1 family members also activate extracellular signal-regulated protein kinases (ERKs) and ternary-complex factor (12) . The signaling pathway by which the small GTPases regulate their diverse cellular functions is an evolving area of investigation.
In mammalian cells, p21-activated kinases (Paks) are identified as one target of the small GTPases Cdc42 and Rac1, and binding of GTP-bound GTPases to Pak1 stimulates its kinase activity via autophosphorylation (13) .
Expression of the activated T423E Pak1 mutant triggers the formation of lamellipodia, dissolution of stress fibers, and dissolution of focal adhesion complexes in fibroblast cells (14, 15) . Expression of another kinase-active Pak1 mutant with a mutation in GTPase binding-sites, H83, 86L, supports the formation of actin ruffles (16) .
The Pak1 contains five potential SH3 domains (16, 17) . In addition to kinase activity, SH3 domains of Pak1 have been implicated in cytoskeletal changes and Pak1 localization probably via their interaction with adapter molecules such as Nck, guanine nucleotide factor PIX and paxillin (18) (19) (20) . Pak1 kinase activity is essential for the formation of polarized lamellipodia at the leading edge (21) and for actin-myosin-mediated cytoskeletal changes involving MLC phosphorylation (22) . Pak1 also activates a number of signaling pathways, including p38MAPK, ERKs, JNK and NF-κB (12, 23) . Expression of the kinase-dead K299R Pak1 mutant blocks the transformation of Rat1 Pak1 were transfected and selected with hygromycin. Expression of Pak1 mutants was verified by immunoblotting using anti-HA mAb.
MATERIALS AND METHODS

Cell
Cell Migration and Immunoflurescence Assays. The cell migration assays were performed using the Boyden chambers using a confocal microscope (4). T423E cells were induced for 7 Cell Proliferation and Soft-Agar Assays. Cell proliferation assays were performed using MTT dye method as described (4) . Colony growth assays were performed as described previously (26) . Briefly 1 ml of solution of 0.6% DIFCO Agar in DMEM supplemented with 10 % FBS with insulin was layered onto 60 × 15 mm tissue culture plates. MCF-7 cell (10,000 cells) were mixed with 1 ml of 0.36% Bactoagar solution in DMEM prepared in a similar manner and layered on top of the 0.6% Bactoagar layer. Plates were incubated at 37°C in 5% CO 2 for 21 days. For cells expressing T423 Pak1, doxycycline (1µg/ml) was added where indicated. As a positive control HRG 10 ng/ml was also included in the medium.
When indicated, some cultures were treated with MEK1/2 inhibitor PD980599 (10 µM), 8
RESULTS AND DISCUSSION
Characterization of Inducible Expression of Kinase-active T423E Pak1 in Epithelial
Cancer Cells -To study the influence of Pak1 kinase on the biology of epithelial breast cancer cells, we established stable cell lines with inducible expression of the activated form of Pak1 under the control of the tetracycline regulated promoter. We used the T423E Pak1 mutant, which behaves as activated Pak1 kinase but retains its ability to bind Cdc42 and Rac1 (16, 21) . We also used another stable clone expressing the H83, 86L Pak1 mutant, which lacks the ability to bind Cdc42/Rac1 but behaves as an activated Pak1 kinase (16, 21) .
These Pak1 mutants allowed us to differentiate the effects that were caused by sequestering of Cdc42/Rac1, Pak1 kinase activity, or both. Cells expressing T423E Pak1 showed the presence of filopodia and HA-Pak1 was predominantly localized at the cell periphery that corresponds to the filopodia structures ( Fig. 2A) . Cells expressing T423E Pak1 showed very little stress fibers compared with vector-transfected cells ( Fig. 2A) and exhibited scattered phenotype. Thirty to forty percent of cells expressing T423E Pak1 generated a leading edge reminiscent of motile phenotype.
In contrast, cells expressing H83, 86L Pak1 showed lower levels of filopodia or stressfibers, but exhibited extensive membrane ruffling to which HA-Pak1 staining was localized. Fig. 3C) . When vector transfected cells were exposed to doxycycline; the p42/44 MAP K pathway was not induced (data not shown).
To address the p ossibility that activation of p42/44 MAPK contributed to the anchorage-independent growth by active Pak1 mutants, the soft agar experiment was repeated in the presence or absence of PD98059, a specific MAPK inhibitor, or 12 SB203580, a specific p38 MAPK inhibitor. As illustrated in Fig. 3D , inclusion of a nontoxic dose of PD98059 blocked the T423E Pak1-mediated increase in anchorage-independent growth; inclusion of SB203580 had a small inhibitory effect compared to PD98059.
Nonspecific inhibitory effects of PD98059 did not cause the observed blockade effect of PD98059 on anchorage-independent growth, because it failed to suppress the anchorageindependent growth supported by HRG treatment (Fig. 3D) . These results suggest that Pak1 
